Delisting Determination, The Nasdaq Stock Market, LLC, November 20, 2023,
RVL Pharmaceuticals plc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of RVL Pharmaceuticals plc, effective
at the opening of the trading session on November 30, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on October 12, 2023.
The Company did not appeal the Staff determination to the Hearings Panel.
The Company securities were suspended on October 23, 2023. The Staff
determination to delist the Company securities became final on
October 23, 2023.